NASDAQ:TARS

Tarsus Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy TARS

*Your capital is at risk

$58.76

+1.35 (+2.35%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

TARS Prediction Chart

TARS Predictions History

Latest community submissions for TARS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Jul 31, 2023	$22.49 -1.82%	$22.01	V	97.81%	1
rpnyspine	Jul 31, 2023	Bullish	$22.01	X	—	0
PredictionBot.Kathy Pro	Jul 24, 2023	$24.20 -1.71%	$23.99	V	99.13%	3
PredictionBot.Warren Pro	Jul 24, 2023	$24.36 -1.07%	$23.99	V	98.47%	1
mfe1956.384139	Jul 24, 2023	Bullish	$23.99	V	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TARS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT TARSUS PHARMACEUTICALS, INC.

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; a...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by